A combined index of structure and function for staging glaucomatous damage

Area of Science:

• Ophthalmology
• Medical Diagnostics
• Glaucoma Research

Background:

• Glaucoma is a leading cause of irreversible blindness.
• Accurate staging and detection of glaucomatous damage are crucial for timely intervention.
• Current methods often rely on isolated structural or functional measures.

Purpose of the Study:

• To introduce and evaluate a novel Combined Structure and Function Index (CSFI).
• To assess the CSFI's efficacy in detecting and staging glaucomatous damage.
• To compare the CSFI's performance against individual structural and functional indices.

Main Methods:

• An observational study included 333 glaucomatous eyes and 330 healthy eyes.
• Retinal ganglion cell (RGC) estimates were derived from standard automated perimetry and spectral domain optical coherence tomography.
• The CSFI was calculated as the percentage of RGC loss; its diagnostic performance was evaluated using receiver operating characteristic curves.

Main Results:

• The mean CSFI was significantly higher in both perimetric (41%) and preperimetric (17%) glaucoma groups compared to healthy controls.
• The CSFI demonstrated superior performance in detecting perimetric and preperimetric glaucoma.
• The CSFI effectively differentiated among early, moderate, and advanced stages of visual field loss.

Conclusions:

• A combined index of ocular structure and function (CSFI) offers improved diagnostic capabilities for glaucoma.
• The CSFI is more effective than isolated measures for detecting glaucoma and classifying disease severity.
• This novel index holds promise for enhanced glaucoma management and patient care.